UPDATE 1-Medivation sets June 1 deadline for shareholder consent on board revamp

PARIS, June 1 (Reuters) - U.S. cancer drug company

Medivation Inc set June 1 as the deadline for

shareholders to give their written consent to remove and replace

its board of directors, after French drugmaker Sanofi

submitted a notice.

Read more